OSEL Devices Ltd Q2 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Published 16 Jul 2026 | Healthcare Equipment & Supplies | Market Cap: ₹743 Cr

Expecting good growth driven primarily by Philips mobile phone sales, especially with smartphones adding volume. The company is targeting overall growth of 20%-25% in the coming years (Page 13).

From OSEL Devices Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.

Price

401

Market Cap

₹743 Cr

P/E Ratio

25.4

How does OSEL Devices Ltd rank in Healthcare Equipment & Supplies?

Compare OSEL Devices Ltd against every Healthcare Equipment & Supplies company this quarter on revenue, margins and earnings-call signals.

View Healthcare Equipment & Supplies leaderboard →

📊 Revenue & Sales Performance

  • Expecting good growth driven primarily by Philips mobile phone sales, especially with smartphones adding volume.
  • LED segment has huge market potential with ongoing OEM orders and expected export sales contributing to growth.
  • Hearing aids segment projected to grow steadily at 20%-25% overall.
  • Feature phone market targeted to capture a significant share of the INR 9,000-10,000 crore market, aiming to become a leading player in 2-3 years.
  • Currently seeing around 2,000 feature phone activations daily, with realization per phone around INR 850 and EBITDA margins of 15%-20%.
  • Smartphone introduction planned by December 2025 with production scale-up expected by March 2026.
  • Continued expansion in distribution network across India, now present in 18 states with 120 distributors.
  • Long-term receivable cycle targeted within 90 days to support growth.
  • Overall company growth estimated at 20%-25% annually.

📈 Profitability & Margins

  • The company is targeting overall growth of 20%-25% in the coming years (Page 13).
  • Growth drivers include:
  • - Philips mobile phone sales, especially increase in smartphone volumes.
  • - LED segment with large potential through OEM and export orders.
  • - Hearing aids segment expected steady growth of 20%-25%, with retail sales improving bottom line.
  • Feature phone business will support marketing expenses for smartphones as the latter scales.
  • Current EBITDA margin in feature phones is around 15%-20% (Page 9).
  • Profits expected to improve as marketing and sales stabilize and manufacturing efficiencies increase (Page 19).
  • The company is optimistic due to ongoing tie-ups, product pipeline, and business efforts but refrains from providing exact numbers (Page 19).

🏗️ Capital Expenditure Plans

  • Currently, no immediate capex planned for mobile phone division expansion; capex will be considered once stable, regular orders (3-5 lakh units/month) are established (Page 6).
  • Capex will be required later to set up in-house manufacturing once monthly order volumes stabilize (Page 6).
  • Land acquisition at JNPT (five acres) approved for warehousing and manufacturing setup aimed for domestic, international, and re-export business, indicating future capital investment in infrastructure (Page 11).
  • Additional working capital requirements anticipated as business grows; company has good banking support for these needs (Page 13).
  • Investments raised (preferential issues) have been utilized primarily for working capital rather than fixed assets (Page 7).
  • OEM business ramp-up and export orders planned, implying potential future investments aligned with scaling production (Page 12).

💰 Fundraising & Capital Structure

  • Currently, OSEL Devices Limited is well-positioned in terms of working capital requirements for the near term.
  • The company has good banking support in place for additional working capital needs as business grows.
  • No immediate fundraising through debt or equity is explicitly planned; working capital limits were recently increased in anticipation of higher business volume.
  • Short-term debt usage has increased alongside holding cash in mutual funds to manage liquidity efficiently.
  • Future additional working capital requirements may arise if business growth targets are met, for which the company has banking support.
  • No specific plans indicated for fresh equity fundraising or long-term debt issuance at this stage.

📋 Order Book & Pipeline

  • Current order book: Around 70 to 80 orders in hand, expected to be delivered before March 2026.
  • Large ongoing order: Kotak order with over 100+ branches completed, continuing deliveries across Mumbai, Delhi, and nationwide.
  • Mobile phone orders: Initial pilot order of 1 lakh units completed, followed by a 3 lakh units order, targeting 5 lakh units order by December.
  • OEM LED business: Already commenced with INR 20 crores of business done in the first half, with additional export orders and more tie-ups in the pipeline.
  • Pipeline: Additional new international and domestic orders in OEM LED and mobile segments expected for growth.
  • Overall: Good order visibility with continuous inflow of new tie-ups and incremental orders across segments.

Key Metrics

Frequently Asked Questions

What were OSEL Devices Ltd Q2 FY26 results?

Expecting good growth driven primarily by Philips mobile phone sales, especially with smartphones adding volume. The company is targeting overall growth of 20%-25% in the coming years (Page 13).

What is OSEL Devices Ltd share price analysis?

OSEL Devices Ltd currently shows a neutral. The stock trades at a P/E of 25.4 with a market cap of ₹743 Cr. Investors should review the full earnings analysis for detailed insights.

Is OSEL Devices Ltd planning capital expenditure?

Currently, no immediate capex planned for mobile phone division expansion; capex will be considered once stable, regular orders (3-5 lakh units/month) are established (Page 6).

Keep OSEL Devices Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.

What OSEL Devices Ltd's management said in earlier quarters

Others in Healthcare Equipment & Supplies this season

  • Earkart (Q2 FY26)

    Earkart has already secured government orders worth approximately ₹9 crores in the current fiscal year (Page 8, 7th excerpt). Key concall takeaways from…

  • QMS Medical (Q2 FY26)

    The only related transaction noted is the recent acquisition of Saarathi increasing stake from 51% to 76%, but no fundraising details were shared with respect…

  • Prevest Denpro Ltd (Q2 FY26)

    100 crores in revenue within three years. Key concall takeaways from Prevest Denpro Ltd's Q2 FY26 earnings call — and how it ranks against sector peers.

  • Vasa Denticity Ltd (Q2 FY26)

    Growth levers include increasing active customers (e.g., from 60,000 to 100,000 monthly) and increasing wallet share per customer (e.g., from 15% to 40%). Key…